BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 37199886)

  • 1. Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body.
    Egawa N
    Int J Clin Oncol; 2023 Aug; 28(8):956-964. PubMed ID: 37199886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus: often harmless but in some cases carcinogenic.
    Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and epidemiology of HPV infection and cervical cancer.
    Castellsagué X
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between human papillomavirus and oral cancer: a literature review.
    Shigeishi H
    Int J Clin Oncol; 2023 Aug; 28(8):982-989. PubMed ID: 36929094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenesis and management of human papillomavirus-associated cervical cancer.
    Kusakabe M; Taguchi A; Sone K; Mori M; Osuga Y
    Int J Clin Oncol; 2023 Aug; 28(8):965-974. PubMed ID: 37294390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations.
    Prigge ES; von Knebel Doeberitz M; Reuschenbach M
    Mutat Res Rev Mutat Res; 2017; 772():51-66. PubMed ID: 28528690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening.
    Li T; Chen S; Li X; Wu Z; Zhao Y; Cui J; Liu B; Chen F; Zhang X; Qiao Y; Chen W
    Virol J; 2023 Jun; 20(1):116. PubMed ID: 37280665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining our understanding of cervical neoplasia and its cellular origins.
    Doorbar J; Griffin H
    Papillomavirus Res; 2019 Jun; 7():176-179. PubMed ID: 30974183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
    Pyeon D; Newton MA; Lambert PF; den Boon JA; Sengupta S; Marsit CJ; Woodworth CD; Connor JP; Haugen TH; Smith EM; Kelsey KT; Turek LP; Ahlquist P
    Cancer Res; 2007 May; 67(10):4605-19. PubMed ID: 17510386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women.
    Ngamkham J; Boonmark K; Phansri T
    Asian Pac J Cancer Prev; 2016; 17(3):1129-34. PubMed ID: 27039737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of cervical papillomavirus infections. Recent knowledge].
    Mougin C; Dalstein V; Prétet JL; Gay C; Schaal JP; Riethmuller D
    Presse Med; 2001 Jun; 30(20):1017-23. PubMed ID: 11433694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of HPV Mediated Carcinogenesis and Tumor Progression.
    Cosper PF; Bradley S; Luo L; Kimple RJ
    Semin Radiat Oncol; 2021 Oct; 31(4):265-273. PubMed ID: 34455982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico.
    Muñoz-Bello JO; Carrillo-García A; Lizano M
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillomaviruses in human disease: Part II. Molecular biology and immunology of papillomavirus infections and carcinogenesis.
    von Knebel Doeberitz M
    Eur J Med; 1992 Dec; 1(8):485-91. PubMed ID: 1341208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis.
    Chen L; Qiu X; Zhang N; Wang Y; Wang M; Li D; Wang L; Du Y
    Biosci Trends; 2017 Sep; 11(4):383-388. PubMed ID: 28717061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses.
    Okodo M; Okayama K; Sasagawa T; Teruya K; Settsu R; Mizuno S; Ishii Y; Oda M
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.
    La Ruche G; You B; Mensah-Ado I; Bergeron C; Montcho C; Ramon R; Touré-Coulibaly K; Welffens-Ekra C; Dabis F; Orth G
    Int J Cancer; 1998 May; 76(4):480-6. PubMed ID: 9590121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.
    Vonsky M; Shabaeva M; Runov A; Lebedeva N; Chowdhury S; Palefsky JM; Isaguliants M
    Biochemistry (Mosc); 2019 Jul; 84(7):782-799. PubMed ID: 31509729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA as viral transcription tuners in HPV-mediated cervical carcinogenesis.
    Shishodia G; Verma G; Das BC; Bharti AC
    Front Biosci (Schol Ed); 2018 Jan; 10(1):21-47. PubMed ID: 28930517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.